CENTRAX

This brand name is authorized in Ireland

Active ingredients

The drug CENTRAX contains one active pharmaceutical ingredient (API):

1 Prazepam UNII Q30VCC064M - PRAZEPAM

Prazepam is a benzodiazepine derivative and has depressant effects on the central nervous system. Benzodiazepines act at the level of the limbic, thalamic, and hypothalamic regions of the CNS and can produce any level of CNS depression required including sedation, hypnosis, skeletal muscle relaxation, and anticonvulsant activity. Read about Prazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CENTRAX Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05BA11	Prazepam	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BA Benzodiazepine derivatives
Discover more medicines within N05BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: IE	Health Products Regulatory Authority	Identifier(s): 17124